首页> Hepatobiliary & pancreatic diseases international : HBPD INT> Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer.

Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Trisheena,Harricharran

第一单位： Department of Biological Sciences, Hunter College of The City University of New York, New York, NY 10065, USA; The Graduate Center Departments of Biology and Biochemistry, The City University of New York, New York, NY 10016, USA; Hunter College Center for Cancer Health Disparities Research (CCHDR), New York, NY 10065, USA.

作者： Trisheena,Harricharran ^[1] ; Olorunseun O,Ogunwobi ^[2]

作者单位： Department of Biological Sciences, Hunter College of The City University of New York, New York, NY 10065, USA; The Graduate Center Departments of Biology and Biochemistry, The City University of New York, New York, NY 10016, USA; Hunter College Center for Cancer Health Disparities Research (CCHDR), New York, NY 10065, USA. ^[1] Department of Biological Sciences, Hunter College of The City University of New York, New York, NY 10065, USA; The Graduate Center Departments of Biology and Biochemistry, The City University of New York, New York, NY 10016, USA; Hunter College Center for Cancer Health Disparities Research (CCHDR), New York, NY 10065, USA; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA. Electronic address: ogunwobi@genectr.hunter.cuny.edu. ^[2]

关键词 Oxytocin Oxytocin receptor Pancreatic cancer